THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 136 | +1 | 64.22M | $12.02B | +9 | −10 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 8.02M | — | $1.07B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Glenview Capital ✦ | 4.67M | — | $620.68M | 13.1% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.14M | — | $284.42M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 1.78M | — | $237.33M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 1.65M | — | $220.14M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 1.56M | — | $208.18M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.38M | — | $183.33M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 713.98K | — | $94.98M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Greenlight Capital (DME Capital) ✦ | 597.68K | — | $79.51M | 3.9% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 341.25K | — | $45.40M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 11 | Point72 Asset Management ✦ | 336.26K | — | $44.73M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 299.64K | — | $39.86M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 206.38K | — | $27.45M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 96.64K | — | $12.86M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 86.82K | — | $11.55M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 46.53K | — | $6.19M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Two Sigma Investments ✦ | 14.60K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Harris Associates (Oakmark) ✦ | 3.90K | — | $518,817 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 686 tenedores, 81.68M acciones, $13.63B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 4.03K acc. · $1.06M
Director · 5.48K acc. · $1.44M
Director · 2.50K acc. · $662,079
Director · 10.00K acc. · $2.63M
Officer · 24.00K acc. · $6.39M
Officer, Director · 7.90K acc. · $2.17M
Officer, Director · 17.22K acc. · $4.71M
Officer, Director · 24.88K acc. · $6.82M
Officer, Director · 36.66K acc. · $10.22M
Officer, Director · 13.34K acc. · $3.71M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología